Trgovina Roche Holding AG - ROGz CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 1.2 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.014885% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.007337% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | CHF | ||||||||
| Kritje | 20% | ||||||||
| Borza | Switzerland | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Roche Holding AG ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Ključni statistični podatki
| Predhodno. Zapri* | 288.2 |
| Odpri* | 288.8 |
| Enoletna sprememba* | -12.56% |
| Dnevni razpon* | 283.8 - 290.4 |
| Razpon 52 wk | 256.05-335.85 |
| Povprečni obseg (10 dni) | 1.56M |
| Povprečni obseg (3 meseci) | 27.98M |
| Tržna kapitalizacija | 235.23B |
| Razmerje P/E | 18.77 |
| Število delnic v obtoku | 799.18M |
| Prihodki | 63.28B |
| EPS | 15.36 |
| Dividenda (donosnost v %) | 3.29632 |
| Beta | 0.76 |
| Datum naslednjega zaslužka | Jul 27, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| May 31, 2023 | 284.1 | -5.0 | -1.73% | 289.1 | 290.6 | 280.8 |
| May 30, 2023 | 288.2 | -0.9 | -0.31% | 289.1 | 290.2 | 286.7 |
| May 26, 2023 | 290.7 | 1.6 | 0.55% | 289.1 | 291.2 | 286.7 |
| May 25, 2023 | 287.4 | 0.8 | 0.28% | 286.6 | 288.7 | 285.9 |
| May 24, 2023 | 288.2 | 1.2 | 0.42% | 287.0 | 288.8 | 286.3 |
| May 23, 2023 | 285.8 | 0.4 | 0.14% | 285.4 | 287.8 | 284.5 |
| May 22, 2023 | 285.7 | -1.8 | -0.63% | 287.5 | 288.4 | 283.9 |
| May 19, 2023 | 287.1 | 2.1 | 0.74% | 285.0 | 288.7 | 283.9 |
| May 17, 2023 | 283.5 | 1.4 | 0.50% | 282.1 | 284.5 | 281.9 |
| May 16, 2023 | 281.6 | -1.7 | -0.60% | 283.3 | 284.0 | 280.8 |
| May 15, 2023 | 284.2 | -0.7 | -0.25% | 284.9 | 285.5 | 283.1 |
| May 12, 2023 | 283.9 | 2.0 | 0.71% | 281.9 | 284.9 | 281.9 |
| May 11, 2023 | 281.5 | 1.0 | 0.36% | 280.5 | 283.1 | 280.4 |
| May 10, 2023 | 280.2 | -1.8 | -0.64% | 282.0 | 282.0 | 278.8 |
| May 9, 2023 | 282.9 | -1.1 | -0.39% | 284.0 | 284.5 | 281.0 |
| May 8, 2023 | 283.7 | 0.3 | 0.11% | 283.4 | 285.0 | 282.8 |
| May 5, 2023 | 282.8 | 1.4 | 0.50% | 281.4 | 282.9 | 279.9 |
| May 4, 2023 | 281.4 | 1.9 | 0.68% | 279.5 | 281.6 | 278.8 |
| May 3, 2023 | 280.4 | -0.4 | -0.14% | 280.8 | 281.2 | 277.1 |
| May 2, 2023 | 279.9 | -3.0 | -1.06% | 282.9 | 283.0 | 279.4 |
Roche Holding AG Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| Wednesday, June 7, 2023 | ||
| Čas (UTC) (UTC) 12:00 | Država CH
| Dogodek Roche Holding AG at Jefferies Healthcare Conference Roche Holding AG at Jefferies Healthcare ConferenceForecast -Previous - |
| Thursday, June 8, 2023 | ||
| Čas (UTC) (UTC) 06:00 | Država CH
| Dogodek Roche Holding AG at Exane CEO Conference Roche Holding AG at Exane CEO ConferenceForecast -Previous - |
| Monday, June 12, 2023 | ||
| Čas (UTC) (UTC) 14:30 | Država CH
| Dogodek Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and NephrologyForecast -Previous - |
| Wednesday, June 14, 2023 | ||
| Čas (UTC) (UTC) 12:00 | Država CH
| Dogodek Roche Holding AG at Stifel Swiss Equities Conference Roche Holding AG at Stifel Swiss Equities ConferenceForecast -Previous - |
| Čas (UTC) (UTC) 15:00 | Država CH
| Dogodek Roche Holding AG at Goldman Sachs Healthcare Conference Roche Holding AG at Goldman Sachs Healthcare ConferenceForecast -Previous - |
| Tuesday, June 20, 2023 | ||
| Čas (UTC) (UTC) 07:00 | Država CH
| Dogodek Roche Holding AG at Citi European Healthcare Conference Roche Holding AG at Citi European Healthcare ConferenceForecast -Previous - |
| Wednesday, June 21, 2023 | ||
| Čas (UTC) (UTC) 08:00 | Država CH
| Dogodek Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian Conference Roche Holding AG at Deutsche Bank dbAccess German Swiss Austrian ConferenceForecast -Previous - |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 63281 | 62801 | 58323 | 61466 | 56846 |
| Prihodki | 63281 | 62801 | 58323 | 61466 | 56846 |
| Celotni stroški prihodkov | 18511 | 19348 | 15900 | 17377 | 16445 |
| Bruto dobiček | 44770 | 43453 | 42423 | 44089 | 40401 |
| Celotni odhodki iz poslovanja | 45805 | 44646 | 39780 | 43918 | 42077 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 12124 | 12100 | 12075 | 13208 | 12453 |
| Raziskave in razvoj | 14050 | 13707 | 12151 | 11690 | 11048 |
| Depreciation / Amortization | 378 | 351 | 446 | 268 | 183 |
| Nenavadni odhodki (prihodki) | 2569 | 376 | 426 | 2677 | 3945 |
| Other Operating Expenses, Total | -1827 | -1236 | -1218 | -1302 | -1997 |
| Prihodki iz poslovanja | 17476 | 18155 | 18543 | 17548 | 14769 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -1040 | -677 | -463 | -758 | -419 |
| Drugo, neto | -109 | -80 | -115 | -176 | -202 |
| Čisti dobiček pred obdavčitvijo | 16327 | 17398 | 17965 | 16614 | 14148 |
| Čisti dobiček po davkih | 13531 | 14935 | 15068 | 14108 | 10830 |
| Manjšinski delež | -1110 | -1005 | -773 | -611 | -365 |
| Čisti dobiček pred dodatnimi postavkami | 12421 | 13930 | 14295 | 13497 | 10465 |
| Čisti dobiček | 12421 | 13930 | 14295 | 13497 | 10500 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 12421 | 13930 | 14295 | 13497 | 10465 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 12421 | 13930 | 14295 | 13497 | 10500 |
| Prilagoditev za redčenje | -1 | -1 | -1 | -2 | -1 |
| Popravljen čisti dobiček | 12420 | 13929 | 14294 | 13495 | 10499 |
| Popravljene ponderirane povprečne delnice | 808 | 860 | 865 | 864 | 860 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 15.3713 | 16.1965 | 16.5249 | 15.6192 | 12.1674 |
| Dividends per Share - Common Stock Primary Issue | 9.5 | 9.3 | 9.1 | 9 | 8.7 |
| Popravljen normalizirani dobiček na enoto čistega dobička | 17.9847 | 16.5778 | 16.9515 | 18.2807 | 15.702 |
| Skupaj izredne postavke | 35 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| Skupni prihodki | 30986 | 32295 | 32088 | 30713 |
| Prihodki | 30986 | 32295 | 32088 | 30713 |
| Celotni stroški prihodkov | 8949 | 9562 | 10279 | 9069 |
| Bruto dobiček | 22037 | 22733 | 21809 | 21644 |
| Celotni odhodki iz poslovanja | 25057 | 20748 | 24010 | 20636 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 6479 | 5645 | 6544 | 5556 |
| Raziskave in razvoj | 7422 | 6628 | 7017 | 6690 |
| Depreciation / Amortization | 196 | 182 | 177 | 174 |
| Nenavadni odhodki (prihodki) | 2584 | -15 | 619 | -243 |
| Other Operating Expenses, Total | -573 | -1254 | -626 | -610 |
| Prihodki iz poslovanja | 5929 | 11547 | 8078 | 10077 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -568 | -472 | -524 | -151 |
| Drugo, neto | -19 | -90 | -43 | -39 |
| Čisti dobiček pred obdavčitvijo | 5342 | 10985 | 7511 | 9887 |
| Čisti dobiček po davkih | 4370 | 9161 | 6719 | 8216 |
| Manjšinski delež | -479 | -631 | -592 | -413 |
| Čisti dobiček pred dodatnimi postavkami | 3891 | 8530 | 6127 | 7803 |
| Čisti dobiček | 3891 | 8530 | 6127 | 7803 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 3891 | 8530 | 6127 | 7803 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 3891 | 8530 | 6127 | 7803 |
| Prilagoditev za redčenje | -1 | 0 | -1 | 0 |
| Popravljen čisti dobiček | 3890 | 8530 | 6126 | 7803 |
| Popravljene ponderirane povprečne delnice | 806 | 810 | 858 | 862 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 4.8263 | 10.5309 | 7.13986 | 9.0522 |
| Dividends per Share - Common Stock Primary Issue | 9.5 | 0 | 9.3 | 0 |
| Popravljen normalizirani dobiček na enoto čistega dobička | 7.42355 | 10.5195 | 7.78732 | 8.8218 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 33816 | 35627 | 32942 | 31254 | 32244 |
| Denarna sredstva in kratkoročne naložbe | 9767 | 13031 | 12334 | 11858 | 13118 |
| Cash | 2841 | 5028 | 4536 | 4769 | 4139 |
| Denarna sredstva in ustrezniki | 2150 | 1822 | 1191 | 1306 | 2542 |
| Kratkoročne naložbe | 4776 | 6181 | 6607 | 5783 | 6437 |
| Celotne terjatve, neto | 13866 | 12651 | 11740 | 12150 | 11487 |
| Accounts Receivable - Trade, Net | 11527 | 10719 | 10056 | 10343 | 9687 |
| Total Inventory | 8605 | 7715 | 7194 | 6055 | 6621 |
| Prepaid Expenses | 1202 | 1869 | 1153 | 795 | 683 |
| Other Current Assets, Total | 376 | 361 | 521 | 396 | 335 |
| Total Assets | 88151 | 92317 | 86138 | 83091 | 78517 |
| Property/Plant/Equipment, Total - Net | 24208 | 24412 | 23270 | 23318 | 21818 |
| Property/Plant/Equipment, Total - Gross | 49408 | 48205 | 45664 | 45041 | 41822 |
| Accumulated Depreciation, Total | -25200 | -23793 | -22394 | -21723 | -20004 |
| Goodwill, Net | 10820 | 10809 | 9249 | 12456 | 8948 |
| Intangibles, Net | 9685 | 12117 | 12017 | 8358 | 9346 |
| Long Term Investments | 971 | 1069 | 1276 | 739 | 602 |
| Note Receivable - Long Term | 125 | 133 | 125 | 128 | 132 |
| Other Long Term Assets, Total | 8526 | 8150 | 7259 | 6838 | 5427 |
| Total Current Liabilities | 27239 | 38416 | 25401 | 24119 | 23033 |
| Accounts Payable | 3861 | 3844 | 3317 | 3176 | 2847 |
| Accrued Expenses | 12180 | 12497 | 11205 | 11214 | 10676 |
| Notes Payable/Short Term Debt | 2191 | 14618 | 2189 | 1694 | 722 |
| Current Port. of LT Debt/Capital Leases | 2071 | 833 | 2126 | 341 | 1971 |
| Other Current Liabilities, Total | 6936 | 6624 | 6564 | 7694 | 6817 |
| Total Liabilities | 60159 | 67828 | 49797 | 50344 | 50895 |
| Total Long Term Debt | 22282 | 17101 | 11096 | 13547 | 16077 |
| Long Term Debt | 21391 | 16076 | 10220 | 12668 | 16075 |
| Capital Lease Obligations | 891 | 1025 | 876 | 879 | 2 |
| Deferred Income Tax | 645 | 628 | 353 | 298 | 384 |
| Minority Interest | 4023 | 3856 | 3432 | 3120 | 2744 |
| Other Liabilities, Total | 5970 | 7827 | 9515 | 9260 | 8657 |
| Total Equity | 27992 | 24489 | 36341 | 32747 | 27622 |
| Common Stock | 107 | 160 | 160 | 160 | 160 |
| Retained Earnings (Accumulated Deficit) | 38937 | 34161 | 45571 | 40524 | 34935 |
| Unrealized Gain (Loss) | -59 | -60 | 106 | 15 | 28 |
| Other Equity, Total | -10993 | -9772 | -9496 | -7952 | -7501 |
| Total Liabilities & Shareholders’ Equity | 88151 | 92317 | 86138 | 83091 | 78517 |
| Total Common Shares Outstanding | 799.181 | 800.403 | 853.126 | 855.756 | 854.428 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 33816 | 30321 | 35627 | 31260 |
| Denarna sredstva in kratkoročne naložbe | 9767 | 6808 | 13031 | 8017 |
| Denarna sredstva in ustrezniki | 4991 | 4315 | 6850 | 5000 |
| Kratkoročne naložbe | 4776 | 2493 | 6181 | 3017 |
| Celotne terjatve, neto | 11919 | 11078 | 11126 | 11809 |
| Accounts Receivable - Trade, Net | 11606 | 10809 | 10806 | 11656 |
| Total Inventory | 8605 | 8292 | 7715 | 8319 |
| Other Current Assets, Total | 3525 | 4143 | 3755 | 3115 |
| Total Assets | 88151 | 86736 | 92317 | 87887 |
| Property/Plant/Equipment, Total - Net | 24208 | 24324 | 24412 | 24300 |
| Goodwill, Net | 10820 | 11160 | 10809 | 10623 |
| Intangibles, Net | 9685 | 11735 | 12117 | 12510 |
| Other Long Term Assets, Total | 9622 | 9196 | 9352 | 9194 |
| Total Current Liabilities | 27239 | 27409 | 38416 | 25193 |
| Payable/Accrued | 4556 | 3896 | 4637 | 4241 |
| Notes Payable/Short Term Debt | 2191 | 2976 | 14618 | 2530 |
| Current Port. of LT Debt/Capital Leases | 1769 | 2405 | 504 | 1196 |
| Other Current Liabilities, Total | 18723 | 18132 | 18657 | 17226 |
| Total Liabilities | 60159 | 61547 | 67828 | 50073 |
| Total Long Term Debt | 21391 | 22369 | 16076 | 11285 |
| Long Term Debt | 21391 | 22369 | 16076 | 11285 |
| Deferred Income Tax | 645 | 690 | 628 | 499 |
| Minority Interest | 4023 | 3757 | 3856 | 3619 |
| Other Liabilities, Total | 6861 | 7322 | 8852 | 9477 |
| Total Equity | 27992 | 25189 | 24489 | 37814 |
| Common Stock | 107 | 107 | 160 | 160 |
| Retained Earnings (Accumulated Deficit) | 38937 | 35740 | 34161 | 46686 |
| Unrealized Gain (Loss) | -59 | -151 | -60 | -90 |
| Other Equity, Total | -10993 | -10507 | -9772 | -8942 |
| Total Liabilities & Shareholders’ Equity | 88151 | 86736 | 92317 | 87887 |
| Total Common Shares Outstanding | 799.181 | 800.579 | 800.403 | 854.261 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | 13531 | 14935 | 15068 | 14108 | 10865 |
| Denarna sredstva iz poslovanja | 18415 | 20976 | 18566 | 22385 | 19979 |
| Denarna sredstva iz poslovanja | 2906 | 2887 | 2808 | 2760 | 2292 |
| Amortization | 938 | 1556 | 1750 | 1532 | 1294 |
| Nedenarne postavke | 9267 | 7718 | 6227 | 8883 | 10308 |
| Cash Taxes Paid | 4102 | 3343 | 3236 | 3543 | 3288 |
| Denarna sredstva Plačane obresti | 557 | 407 | 422 | 624 | 593 |
| Spremembe v obratnem kapitalu | -8227 | -6120 | -7287 | -4898 | -4780 |
| Denarna sredstva pri naložbenju | -3536 | -6552 | -9067 | -8634 | -7195 |
| Kapitalski izdatki | -4797 | -4652 | -7858 | -4896 | -6746 |
| Celotne druge postavke denarnih tokov pri naložbenju | 1261 | -1900 | -1209 | -3738 | -449 |
| Denarna sredstva pri financiranju | -16275 | -13108 | -9666 | -14173 | -10691 |
| Postavke denarnega toka pri financiranju | -2340 | -2333 | -1992 | -1716 | -3316 |
| Total Cash Dividends Paid | -7832 | -8132 | -7964 | -7682 | -7253 |
| Izdaja (odplačilo) dolga, neto | -6103 | 16348 | 290 | -4775 | -122 |
| Učinki deviznih tečajev | -463 | -193 | -181 | -184 | -131 |
| Neto sprememba denarnih sredstev | -1859 | 1123 | -348 | -606 | 1962 |
| Izdaja (odplačilo) delnic, neto | 0 | -18991 |
| Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
|---|---|---|---|---|
| Net income/Starting Line | 13531 | 9161 | 14935 | 8216 |
| Cash From Operating Activities | 18415 | 9509 | 20976 | 8212 |
| Cash From Operating Activities | 2906 | 1429 | 2887 | 1439 |
| Amortization | 938 | 471 | 1556 | 830 |
| Non-Cash Items | 9267 | 3799 | 7718 | 3323 |
| Cash Taxes Paid | 4102 | 2482 | 3343 | 2183 |
| Cash Interest Paid | 557 | 228 | 407 | 243 |
| Changes in Working Capital | -8227 | -5351 | -6120 | -5596 |
| Cash From Investing Activities | -3536 | 1473 | -6552 | 44 |
| Capital Expenditures | -4797 | -2067 | -4652 | -2197 |
| Other Investing Cash Flow Items, Total | 1261 | 3540 | -1900 | 2241 |
| Cash From Financing Activities | -16275 | -13315 | -13108 | -9056 |
| Financing Cash Flow Items | -2340 | -1374 | -2333 | -1211 |
| Total Cash Dividends Paid | -7832 | -7672 | -8132 | -7955 |
| Issuance (Retirement) of Debt, Net | -6103 | -4269 | 16348 | 110 |
| Foreign Exchange Effects | -463 | -202 | -193 | 73 |
| Net Change in Cash | -1859 | -2535 | 1123 | -727 |
| Issuance (Retirement) of Stock, Net | 0 | -18991 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1079 | 21834628 | 173085 | 2023-04-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.8532 | 20045265 | 2208289 | 2022-12-31 | LOW |
| UBS Asset Management (Switzerland) | Investment Advisor | 1.8605 | 13071428 | -86601 | 2023-04-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8316 | 12868041 | 71688 | 2023-04-30 | LOW |
| Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 1.667 | 11711936 | 8879 | 2023-04-30 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 1.5309 | 10755461 | 141764 | 2023-04-30 | LOW |
| Zürcher Kantonalbank (Asset Management) | Bank and Trust | 1.239 | 8704542 | 83328 | 2023-04-30 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.9971 | 7005557 | -46636 | 2023-04-30 | LOW |
| Fidelity International | Investment Advisor | 0.8201 | 5761424 | 114439 | 2023-03-31 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.6721 | 4722004 | 7988 | 2023-04-30 | LOW |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.6581 | 4623374 | -19085 | 2023-03-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.6181 | 4342654 | -1572740 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6015 | 4226034 | 30 | 2023-04-30 | LOW |
| Dodge & Cox | Investment Advisor/Hedge Fund | 0.5908 | 4150400 | 75100 | 2023-03-31 | LOW |
| California Public Employees' Retirement System | Pension Fund | 0.5839 | 4102151 | -453583 | 2022-06-30 | LOW |
| Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5297 | 3721580 | -1515868 | 2023-04-30 | MED |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5147 | 3616071 | -2492 | 2023-04-30 | LOW |
| RBC Global Asset Management (UK) Limited | Investment Advisor | 0.4154 | 2918253 | -77338 | 2023-04-30 | LOW |
| PRIMECAP Management Company | Investment Advisor | 0.3704 | 2602358 | -25668 | 2023-03-31 | LOW |
| Mawer Investment Management Ltd. | Investment Advisor | 0.3591 | 2522750 | 367 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Roche Company profile
O družbi Roche Holding AG
Družba Roche Holding AG (Roche) je zdravstvena družba, ki se ukvarja z raziskavami. Dejavnosti družbe so organizirane v dva oddelka: Farmacevtika in Diagnostika. Oddelek za farmacevtske izdelke sestavljata dva poslovna segmenta: Roche Pharmaceuticals in Chugai. Oddelek za diagnostiko sestavljajo štiri poslovna področja: Diabetes Care, Molekularna diagnostika, Strokovna diagnostika in Diagnostika tkiv. Družba razvija zdravila za različna področja bolezni, vključno z onkologijo, imunologijo, nalezljivimi boleznimi, oftalmologijo in nevroznanostjo. Njeni farmacevtski izdelki vključujejo Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin in Roferon-A. Podjetje ponuja izdelke za raziskovalce, vključno z analizo celic, izražanjem genov, sekvenciranjem genoma in čiščenjem nukleinskih kislin.
| Industry: | Pharmaceuticals (NEC) |
Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com